ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 89 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,934 | -15.1% | 19,388 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $21,133 | -25.3% | 19,388 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $28,306 | +34.8% | 19,388 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $21,000 | -44.7% | 19,388 | -13.4% | 0.01% | -44.4% |
| Q2 2022 | $38,000 | -29.6% | 22,388 | -15.2% | 0.01% | -18.2% |
| Q1 2022 | $54,000 | -45.5% | 26,388 | 0.0% | 0.01% | -42.1% |
| Q4 2021 | $99,000 | -47.3% | 26,388 | -27.5% | 0.02% | -51.3% |
| Q3 2021 | $188,000 | +45.7% | 36,388 | +19.7% | 0.04% | +50.0% |
| Q2 2021 | $129,000 | +74.3% | 30,388 | +118.8% | 0.03% | +62.5% |
| Q1 2021 | $74,000 | +15.6% | 13,888 | +16.8% | 0.02% | 0.0% |
| Q4 2020 | $64,000 | – | 11,888 | -53.9% | 0.02% | – |
| Q3 2020 | $0 | – | 25,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |